Renalytix Investor Relations Material
Latest events
Q3 2024
Renalytix
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Renalytix Plc
Access all reports
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company's lead product candidate is KidneyIntelX, a non-invasive blood test to predict the risk of rapid decline in kidney function, progression to kidney failure, and comorbidities related to Chronic Kidney Disease (CKD), including acute kidney injury, cardiovascular disease, and anemia.
Latest articles
The Birkin Bag: The Story Behind the World's Most Desired Handbag
How the Birkin bag became the world's most sought-after handbag where even the wealthy must earn the right to own one.
12 Jul 2024
The 10 Largest Semiconductor Companies in the World
Discover the top 10 semiconductor companies by market cap, exploring their innovations and business models shaping the tech landscape.
10 Jul 2024
The Rise of Nubank: Changing Latin American Finance
Discover how Nubank revolutionized Latin American banking with innovation, backed by top investors like Berkshire Hathaway.
9 Jul 2024
Ticker symbol
RNLX
Country
đșđž United States